我们用ＥＬＩＳＡ方法检测了１２７例不同类型肝病病人的抗—ＨＣＶ。总的抗—ＨＣＶ阳性率为２７．５６％。重肝和肝细胞癌抗—ＨＣＶ阳性率最高，为５０％，慢活肝和肝硬化次之，分别为３８．１０％和３６．３６％。说明ＨＣＶ感染易导致肝病的慢性化；ＨＣＶ感染与肝细胞癌的发生有着明显的相关性；ＨＣＶ与ＨＢＶ的双重感染增加了重肝的发生率。我们在实验中用四种厂家试剂盒检测，结果表明，不同产家试剂盒抗—ＨＣＶ阳性率不尽相同，但无统计学意义。 We detected anti-HCV in 127 patients with different types of liver disease by ELISA. The total anti-HCV positive rate was 27.56%. The positive rates of anti-HCV in patients with severe hepatitis and hepatocellular carcinoma were the highest, 50%, followed by those with slowly-active liver and cirrhosis were 38.10% and 36.36% respectively. HCV infection can lead to chronic liver disease; HCV infection and hepatocellular carcinoma have a significant correlation; double infection of HCV and HBV increased the incidence of severe liver. We tested in the experiment with four kinds of manufacturers kit, the results showed that different manufacturers of anti-HCV positive rate is not the same, but not statistically significant.